Bio-Rad Laboratories, Inc. Cl B (BIO.B)
AMEX · Special · CUSIP 090572108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BIO.B and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
090572108
Market Cap
Mid Cap · $786 Million
Business: Bio-Rad Laboratories continues to play a leading role in the advancement of scientific discovery by offering a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 7,000 employees and serves more than 100,000 research and industry customers worldwide through the company's global network of operations. Bio-Rad's Life Science Group develops, manufactures, and markets a wide range of laboratory instruments, apparatus, and consumables used for research in functional genomics, proteomics, and food safety. The group ranks among the top five life science companies worldwide. The Clinical Diagnostics Group develops, manufactures, sells, and supports a large portfolio of products for medical screening and diagnostics. Bio-Rad is a leading specialty diagnostics company and its products are recognized as the gold standard for diabetes monitoring and quality control (QC) systems. The company is also well known for its blood virus testing and detection, blood typing, autoimmune and genetic disorders testing, and internet-based software products.

Company Contact

CEO
Norman Schwartz
CFO
Christine A. Tsingos
Headquarters
1000 Alfred Nobel Drive, Hercules, CA 94547
Phone
510-724-7000 · Toll-Free 800-424-6723
Fax
510-741-5815
Investor Relations
510-741-6104 · investor_relations@bio-rad.com
Email Form
Feedback Form »
SEC EDGAR Filings
View filings »